Shots: The approval is based on P-I & P-IV study assessing Actemra 162 mg SC via the pre-filled syringe (PFS) vs Actemra 162 mg SC via the ACTPen & testing safety and efficacy of ACTpen respectively The study demonstrated showing a single dose of Actemra 162 mg SC with ACTpen is bioequivalent to currently used […]Read More
